TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.83M | -39.00M | -40.77M | -43.44M | -37.84M |
| Total Depreciation and Amortization | 1.01M | 1.05M | 1.07M | 1.05M | 1.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.11M | 7.77M | 7.56M | 7.74M | 103.00K |
| Change in Net Operating Assets | 1.50M | -702.00K | -2.00M | -2.28M | -4.87M |
| Cash from Operations | -28.22M | -30.88M | -34.14M | -36.94M | -41.60M |
| Capital Expenditure | -448.00K | -621.00K | -532.00K | -717.00K | -989.00K |
| Sale of Property, Plant, and Equipment | 1.29M | 1.09M | 562.00K | 610.00K | 5.44M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 846.00K | 464.00K | 30.00K | -107.00K | 4.45M |
| Total Debt Issued | 60.00M | -- | -- | -- | -- |
| Total Debt Repaid | -42.42M | -- | -- | -- | -- |
| Issuance of Common Stock | 11.93M | 43.03M | 43.10M | 43.10M | 43.43M |
| Repurchase of Common Stock | -205.00K | -212.00K | -210.00K | -218.00K | -369.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.55M | -- | -- | -- | -- |
| Cash from Financing | 25.75M | 42.81M | 42.89M | 42.89M | 43.06M |
| Foreign Exchange rate Adjustments | -217.00K | 0.00 | -292.00K | -152.00K | 28.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.84M | 12.40M | 8.48M | 5.69M | 5.94M |